Cadila Pharma has appointed Hemant Kumar as President - Supply Chain & Procurement at the company.Hemant shared the update ...

The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Mumbai's real estate sector continues to grow with a record number of high-value sales as billionaires, Bollywood celebrities, and high net-worth individuals make large-scale property investments. In ...

The Patels are promoters of Zydus Lifesciences Limited, formerly known as Cadila Healthcare. Pankaj Raman Patel is the Chairman of the pharmaceutical company. Zydus Family Trust has purchased a ...

Intas Pharmaceuticals, Cadila Pharmaceuticals, Glenmark Pharmaceuticals, Micro Labs, Torrent Pharmaceuticals, Eris Lifesciences, Alkem Laboratories, among others, in a meeting of the Authority held on ...

The Zydus Family Trust, associated with Zydus Lifesciences Limited (formerly Cadila Healthcare Limited), a leading Indian pharmaceutical company, has purchased a ₹200 crore luxury apartment in ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 861.85. On previous ...

Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs ... savings they are able to deliver to healthcare systems. In a new pharmaphorum ...